🇺🇸 FDA
Company

Acumen

Acumen Pharmaceuticals

ABOS biotech USA

Quick answer

Acumen is a biotech company (ABOS) headquartered in NEWTON, MA, USA with 3 tracked pipeline programs.

Pipeline (3)

project

sabirnetug

Alzheimer Disease

Phase 2 · small_molecule · active

1 trials project

ACU193

Alzheimer Disease

Phase 1 · small_molecule · completed

1 trials project

sabirnetug (ACU193)

Alzheimer Disease

Phase 1 · small_molecule · completed

1 trials

Patents (6)

patent

US 9320793

Method for treating a disease associated with soluble, oligomeric species of amy

Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9217024

ADDL receptor polypeptides, polynucleotides and host cells for recombinant produ

Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9006283

Methods of modifying amyloid β oligomers using non-peptidic compounds

Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8962677

Methods of restoring cognitive ability using non-peptidic compounds

Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8507206

Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)

Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7964359

Compositions and methods for the enhancement of soluble amyloid beta oligomer (A

Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)